New VC for The University of Adelaide visits the BHI, TQEH

The new University of Adelaide Vice–Chancellor, Professor Peter Rathjen, visited The Queen Elizabe

16.05.20180 comments

READ MORE +

Helen Palethorpe awarded Dean’s Commendation for Doctoral Thesis Excellence

Congratulations to Dr Helen Palethorpe for being awarded her PhD and receiving a Dean's Commendation for Doctoral Thesis Excellence from The University of Adelaide. Helen completed her PhD with in the Surgical Sciences Research Group at the Basil Hetzel Institute, TQEH, under the supervision of Dr Paul Drew and Dr Eric Smith. Her thesis title was "Fibroblasts, Androgen Signalling and Oesophageal Adenocarcinoma". Her PhD studies were supported by a scholarship from the Faculty of Health Sciences, The University of Adelaide..

In the news: Prof PJ Wormald and A/Prof Sarah Vreugde explain the many uses of chitosan gel

The latest article in The Advertiser's "Wild Science" series once again features BHI based researchers. Professor PJ Wormald and Associate Professor Sarah Vreugde explain how outcomes of research from their ENT Surgery group could soon benefit patients undergoing back surgery. A development grant from The Hospital Research Foundation will fund a clinical trial to investigate the effectiveness of the chitosan gel in improving wound healing and preventing the formation of adhesions after back surgery..

In the news: TQEH gastroenterologist Dr Sam Costello talks about BiomeBank – Australia’s first public stool bank

The Advertiser has a two-page article about Australia's first public stool bank, BiomeBank, established by gastroenterologists Drs Sam Costello and Rob Bryant and located at the Basil Hetzel Institute. Initially the stool is being used in Fecal Microbiota Transplants (FMT) to treat patients with Clostridium difficile infection or Ulcerative Colitis.
Stephanee Hermsen was one of Dr Sam Costello's first patients to undergo this novel therapy, and says that "The next day I was better". Despite cure rates of 80-90% in patients with recurrent C.diff. infections who undergo FMT, the reasons it works are not fully understood. Research is underway at the BHI, TQEH, and with collaborators at other SA hospitals, SAHMRI and Flinders University to "...discover links between the gut microbiome and disease and also to determine whether we can improve disease by modifying the gut microbial environment," Dr Costello says.
21.03.2018

In the news: Prof PJ Wormald and Dr Katharina Richter, ENT Surgery

A story about the "Superbug Solution" was aired on Channel 9 news on Tuesday 6 March. Following successful results in laboratory and pre-clinical research at the Basil Hetzel Institute, a new clinical trial is underway at The Queen Elizabeth Hospital targeting patients undergoing major sinus surgery who are more susceptible to antibiotic resistant infections.
Sweet like chocolate: ABC News, The World Today, Tuesday 6 March 2018
07.03.2018

SA Winner of Fresh Science is Dr Katharina Richter, ENT Surgery

Congratulations to Dr Katharina Richter (Postdoctoral Researcher in ENT Surgery, BHI) as the South Australian winner of Fresh Science. This national competition helps early-career researchers find, and then share, their stories of discovery. Articles/media stories about Kati's research can be found via the following links:
Starving superbugs, then poisoning them: Fresh Science
Sweet like chocolate: ABC News, The World Today, Tuesday 6 March 2018
Superbug solution: Channel 9 news, Tuesday 6 March 2018
Human trials target superbugs: The Lead, Tuesday 6 March 2018
Kati was also a recent winner of the Delegates' Choice Award in the Pitch it Clever competition held at the 2018 Universities Australia Higher Education conference.
06.03.2018

In the news: Dr Anupam Gupta, TQEH Rehabilitation Consultant

TQEH Rehabilitation Consultant Dr Anupam Datta Gupta was interviewed for Ten Eyewitness News Adelaide on Thursday 1 March about the Australian-first clinical trial investigating the benefits of botox injections for stroke patients. Dr Gupta is also undertaking a PhD at the Basil Hetzel Institute, through The University of Adelaide.
Dr Gupta's research is being supported by The Hospital Research Foundation.
06.03.2018

In the news: Professor Tim Price, TQEH oncologist and researcher

An article in The Advertiser, describes a potential new treatment for neuroendocrine cancers using a red chemical dye, called Rose Bengal that was originally used to turn wool and food bright red! Professor Tim Price, an oncologist at The Queen Elizabeth Hospital, heads up the Clinical Trials Group as well as being the research leader of the Colorectal Cancer Research Group at the Basil Hetzel Institute.
21.02.2018